IRIS
GENTILE, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.218
NA - Nord America 3.156
AS - Asia 2.319
SA - Sud America 653
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.418
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.064
RU - Federazione Russa 2.108
SG - Singapore 1.016
CN - Cina 588
BR - Brasile 544
IT - Italia 507
IE - Irlanda 485
HK - Hong Kong 297
SE - Svezia 283
DE - Germania 202
FR - Francia 144
PL - Polonia 142
FI - Finlandia 138
VN - Vietnam 132
IN - India 99
GB - Regno Unito 75
AR - Argentina 44
CA - Canada 42
MX - Messico 34
BD - Bangladesh 31
AT - Austria 26
TR - Turchia 26
NL - Olanda 24
ID - Indonesia 23
EC - Ecuador 21
BE - Belgio 19
JP - Giappone 19
MA - Marocco 16
ZA - Sudafrica 16
UA - Ucraina 15
PK - Pakistan 13
UZ - Uzbekistan 12
VE - Venezuela 12
CI - Costa d'Avorio 10
ES - Italia 10
IQ - Iraq 9
CO - Colombia 8
TN - Tunisia 8
AZ - Azerbaigian 7
KE - Kenya 7
LT - Lituania 7
PE - Perù 7
CL - Cile 6
CZ - Repubblica Ceca 6
NP - Nepal 6
PH - Filippine 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
PY - Paraguay 5
MY - Malesia 4
SA - Arabia Saudita 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
LK - Sri Lanka 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AL - Albania 2
BH - Bahrain 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
UG - Uganda 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
GN - Guinea 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
PA - Panama 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 10.418
Salva come PNG Salva come JPEG
Città #
Ashburn 739
Moscow 673
Singapore 543
Dublin 482
Dallas 378
Chandler 320
Hong Kong 293
Nyköping 214
Beijing 198
Messina 193
San Jose 156
Warsaw 138
Munich 133
The Dalles 111
Lauterbourg 75
Los Angeles 75
Princeton 72
Helsinki 70
Medford 63
Ann Arbor 50
Des Moines 48
Ho Chi Minh City 39
Jacksonville 37
New York 37
Buffalo 36
São Paulo 36
Tianjin 35
Pune 30
Turku 30
Wilmington 29
Council Bluffs 28
Bremen 24
Dearborn 24
Orem 23
Redondo Beach 22
Lappeenranta 21
Chennai 20
Hyderabad 20
Palermo 20
Seattle 20
Cambridge 19
Belo Horizonte 18
Guangzhou 18
Hanoi 18
London 18
Nuremberg 18
Rio de Janeiro 17
Santa Clara 17
Chicago 16
Jinan 16
Rome 16
Tokyo 16
Boardman 15
Brussels 15
Frankfurt am Main 15
Brooklyn 14
Redwood City 14
Milan 13
San Francisco 13
Vienna 13
Boston 12
Brasília 12
Curitiba 12
Duncan 12
Falls Church 12
Houston 12
Shanghai 12
Tashkent 12
Amsterdam 11
Mexico City 11
Montreal 11
Abidjan 10
Catania 10
Guayaquil 10
Jakarta 10
Porto Alegre 10
Zhengzhou 10
Denver 9
Poplar 9
Campinas 8
Changsha 8
Dong Ket 8
Johannesburg 8
Ningbo 8
Shenyang 8
Shenzhen 8
Toronto 8
Baku 7
Da Nang 7
Istanbul 7
Livorno 7
Manaus 7
Nanjing 7
Phoenix 7
San Mateo 7
Taizhou 7
Ankara 6
Atlanta 6
Baghdad 6
Buenos Aires 6
Totale 6.232
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 362
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 326
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 251
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 230
A Nouvel serum MicroRNA signature to screen ATTR 225
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 215
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 210
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 197
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 189
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 174
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 170
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 168
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 168
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 164
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 164
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 161
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 153
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 152
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale 152
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 150
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 147
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 146
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 136
A multicentre study on epidemiology and prevention of needle stick injuries among students of nursing schools 128
A Cyst Compressing the Ulnar Nerve Motor Branch: Ultrasonographic Diagnosis of a Tricking Neuropathy. 128
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 126
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 126
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 125
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 125
Considerable post-partum worsening in a patient with CMT2E 124
"It is not what it seems." Ultrasound findings in a case of unusual iatrogenic ulnar nerve damage. 120
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 115
Use of the International Classification of Functioning, Disability and Health Generic-30 Set for the characterization of outpatients: Italian Society of physical and rehabilitative medicine residents section project 115
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 114
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 114
"Who seeks finds, who compares discovers". Usefulness of ultrasound to assess small nerve branches. 114
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 113
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 113
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 113
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 112
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 111
"Seeing Through the Wall": Ultrasound Application for the Diagnosis and Treatment of Abdominal Pain. 111
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 106
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 105
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 103
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 101
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 101
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 101
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 100
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 99
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 98
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database 98
Early detection of cardiac amyloid deposition in subjects with transthyretin gene mutation by 99mTc-disphosphonate scintigraphy 95
The THAOS: record of patients from our site. 95
Impact of environmental factors and physical activity on disability and quality of life in CIDP 93
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 91
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 90
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 90
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 89
Early detection of cardiac amyloid deposition in patients with transthyretin-related familial amyloid polyneuropathy by 99mTc-diphosphonate scintigraphy 88
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 88
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 86
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 85
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 85
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 83
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 83
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 83
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 82
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 80
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 77
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 77
(TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 75
Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy 74
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 74
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update 73
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy 73
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 72
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 69
Ultrasound guidance increases diagnostic yield of needle EMG in plegic muscle. 69
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 68
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area 63
Rare among rare: Phenotypes of uncommon CMT genotypes 62
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 61
Shear wave elastography of median nerve at wrist and forearm. Heterogeneity of normative values. 59
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the transthyretin amyloidosis outcomes survey (THAOS) 56
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS 55
null 54
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease 36
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy 35
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 33
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 31
null 30
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 27
Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease 25
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 25
Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy 24
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 23
null 22
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study 21
The neurophysiological lesson from the Italian CIDP database 19
Totale 10.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 74 21 16
2021/2022468 14 47 3 16 39 11 47 28 16 22 31 194
2022/20231.267 105 115 77 76 86 114 18 61 562 13 25 15
2023/2024392 27 54 21 27 32 107 16 32 5 25 6 40
2024/20252.205 72 22 48 141 137 141 202 312 441 124 212 353
2025/20265.479 321 462 434 357 478 1.147 682 699 642 257 0 0
Totale 10.746